MetLife Investment Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,170
| Closed | -$97K | – | 2564 |
|
|
2021
Q3 | $97K | Buy |
+2,170
| New | +$97K | ﹤0.01% | 2453 |
|
|
2021
Q2 | – | Sell |
-1,785
| Closed | -$134K | – | 2498 |
|
|
2021
Q1 | $134K | Buy |
1,785
+56
| +3% | +$4.19K | ﹤0.01% | 2221 |
|
|
2020
Q4 | $188K | Hold |
1,729
| – | – | ﹤0.01% | 2017 |
|
|
2020
Q3 | $153K | Hold |
1,729
| – | – | ﹤0.01% | 2016 |
|
|
2020
Q2 | $184K | Hold |
1,729
| – | – | ﹤0.01% | 1960 |
|
|
2020
Q1 | $103K | Buy |
+1,729
| New | +$103K | ﹤0.01% | 2069 |
|
|
2019
Q4 | – | Sell |
-1,837
| Closed | -$191K | – | 2334 |
|
|
2019
Q3 | $191K | Hold |
1,837
| – | – | ﹤0.01% | 1979 |
|
|
2019
Q2 | $170K | Buy |
+1,837
| New | +$170K | ﹤0.01% | 2133 |
|
|
2018
Q4 | – | Sell |
-1,311
| Closed | -$156K | – | 2600 |
|
|
2018
Q3 | $156K | Hold |
1,311
| – | – | ﹤0.01% | 2225 |
|
|
2018
Q2 | $134K | Buy |
+1,311
| New | +$134K | ﹤0.01% | 2115 |
|